var data={"title":"Subcutaneous fat necrosis of the newborn","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Subcutaneous fat necrosis of the newborn</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/contributors\" class=\"contributor contributor_credentials\">Raegan Hunt, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 28, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1052661153\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subcutaneous fat necrosis of the newborn (SCFN) is an uncommon panniculitis of neonates. Classically, red, red-brown, or violaceous subcutaneous nodules and indurated plaques develop on the posterior trunk, buttocks, proximal extremities, or cheeks within the first few weeks of life. Although SCFN is a self-limited condition, recognition of this entity is important, as affected infants require monitoring for associated hypercalcemia or other complications. SCFN generally has a good outcome, with spontaneous resolution of skin disease over weeks to months; however, death from hypercalcemia has been reported in several infants with SCFN [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The epidemiology, pathogenesis, clinical manifestations, diagnosis, and management of SCFN are discussed here. Sclerema neonatorum, a rare, severe panniculitis that develops in critically ill neonates, is discussed separately. (See <a href=\"topic.htm?path=sclerema-neonatorum\" class=\"medical medical_review\">&quot;Sclerema neonatorum&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1524817707\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subcutaneous fat necrosis of the newborn (SCFN) is an uncommon condition, and its precise incidence is unknown. For reference, a retrospective study over a 20-year time period at a tertiary referral center identified 30 infants diagnosed with SCFN and reported a nearly equal male-to-female ratio (1.14:1) [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H1358228590\"><span class=\"h2\">Risk factors</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>SCFN most often develops in full-term (&gt;37 weeks gestational age) neonates who have experienced hypoxia or other perinatal stress. Therapeutic hypothermia with cooling of the body or head for neonatal asphyxia is an additional risk factor [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/3\" class=\"abstract_t\">3</a>]. In many cases of SCFN, the pregnancy was complicated by factors such as maternal diabetes, hypertension or hypothyroidism, preeclampsia, and placental abruption [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/2\" class=\"abstract_t\">2</a>]. Although classically a disease of full-term infants, uncommon cases of SCFN in premature neonates have been described [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H3583928656\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of subcutaneous fat necrosis of the newborn (SCFN) remains elusive. One hypothesis proposes that SCFN results from the combination of local tissue hypoxia and mechanical pressure; another suggests that the enrichment of stearic acids and saturated palmitic acids in neonatal fat predisposes the tissue to crystallization at low temperatures [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/1\" class=\"abstract_t\">1</a>]. As most of the reported cases of SCFN have developed in the setting of hypoxia or hypothermia, these hypotheses are attractive, although the exact pathogenetic mechanisms are unclear.</p><p>Hypercalcemia develops as a potentially life-threatening complication in some cases of SCFN. The specific etiology for this phenomenon is not known. Granulomatous inflammatory cells in SCFN express high levels of 1-alpha-hydroxylase, the enzyme that converts 25-hydroxyvitamin D3 to its active form of 1,25-dihydroxyvitamin D3 [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/5\" class=\"abstract_t\">5</a>]. 1,25-dihydroxyvitamin D3 promotes calcium mobilization from bone and increases intestinal absorption of calcium. Therefore, it is plausible that increased 1,25-dihydroxyvitamin D3 production in affected tissue of SCFN results in secondary hypercalcemia [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/6,7\" class=\"abstract_t\">6,7</a>]. Possible links between SCFN-related hypercalcemia and increased prostaglandin E or parathyroid hormone levels have been postulated; however, prostaglandin E and parathyroid hormone levels are often normal in infants affected by SCFN with hypercalcemia [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/8,9\" class=\"abstract_t\">8,9</a>].</p><p class=\"headingAnchor\" id=\"H2228797353\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Subcutaneous fat necrosis of the newborn (SCFN) typically presents in full-term neonates in the first six weeks of life with erythematous to violaceous nodules or indurated plaques on the cheeks, posterior trunk, buttocks, or proximal extremities (<a href=\"image.htm?imageKey=DERM%2F112136%7EDERM%2F83790\" class=\"graphic graphic_picture graphicRef112136 graphicRef83790 \">picture 1A-B</a>). The chest and abdomen tend to be spared. Lesions are frequently tender.</p><p class=\"headingAnchor\" id=\"H195823984\"><span class=\"h2\">Clinical course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In most cases, SCFN skin nodules and plaques spontaneously regress within weeks to a few months without cutaneous sequelae. There is a single report of an SCFN case with extensive lesions that had not regressed at the age of nine months and required surgical intervention [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/10\" class=\"abstract_t\">10</a>]. In some cases, extensive calcification may develop within lesions or affected fat liquefies into fluctuant bullae [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/11\" class=\"abstract_t\">11</a>]. Uncommonly, scarring or cutaneous atrophy persist at sites of resolved lesions [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/12\" class=\"abstract_t\">12</a>].</p><p>Hypercalcemia, a potentially life-threatening complication of SCFN, occurs in approximately 36 to 56 percent of affected neonates [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/13,14\" class=\"abstract_t\">13,14</a>]. In a study of seven infants with SCFN and severe hypercalcemia (peak serum calcium &ge;3 <span class=\"nowrap\">mmol/L),</span> hypercalcemia was detected within six weeks of life [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/15\" class=\"abstract_t\">15</a>]. However, blood calcium levels should be monitored for up to six months after the onset of skin lesions, as late presentation of SCFN-associated hypercalcemia has been reported [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/16\" class=\"abstract_t\">16</a>]. </p><p>Hypercalcemia may be asymptomatic or may present with irritability, hypotonia, anorexia, or vomiting. Nephrocalcinosis is frequently observed and may persist, but it generally does not cause significant renal dysfunction [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/15,17\" class=\"abstract_t\">15,17</a>]. Metastatic calcification in other tissues, such as pericardium and brain, have also been described in the context of SCFN-associated hypercalcemia [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/18\" class=\"abstract_t\">18</a>].</p><p>Thrombocytopenia, elevated triglycerides, or hypoglycemia may occur in some infants with SCFN [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/2,19\" class=\"abstract_t\">2,19</a>]. In most cases, these abnormalities are mild and transient.</p><p class=\"headingAnchor\" id=\"H1738286987\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of subcutaneous fat necrosis of the newborn (SCFN) may be made clinically. However, if the diagnosis is in question, a skin biopsy can provide histopathologic&nbsp;confirmation (see <a href=\"#H1638911239\" class=\"local\">'Pathology'</a> below). Alternatively, fine-needle aspiration is a minimally invasive procedure that can rapidly establish the diagnosis by cytologic examination [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Magnetic resonance imaging (MRI) and ultrasound may also be useful in the evaluation of the lesions [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/22-24\" class=\"abstract_t\">22-24</a>].</p><p class=\"headingAnchor\" id=\"H1638911239\"><span class=\"h2\">Pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histopathologic findings of subcutaneous fat necrosis include the following [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/25,26\" class=\"abstract_t\">25,26</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lobular panniculitis with a dense infiltrate of histiocytes, eosinophils, and multinucleated giant cells</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Radial crystal cleft spaces in arrays within adipocytes similar to the crystal cleft spaces observed in sclerema neonatorum</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Focal calcification within lesions</p><p/><p class=\"headingAnchor\" id=\"H4233786213\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Conditions that mimic subcutaneous fat necrosis of the newborn (SCFN) include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cold panniculitis</strong> &ndash; Cold panniculitis typically manifests as firm, well-demarcated erythematous plaques at sites where the skin has been in direct contact with cold objects (<a href=\"image.htm?imageKey=DERM%2F83785\" class=\"graphic graphic_picture graphicRef83785 \">picture 2</a>). Generally, cold panniculitis appears within hours to days after the cold exposure and quickly resolves. Facial ice application for management of tachycardia and use of cooling blankets during cardiac surgery have been implicated in cases of cold panniculitis [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/27\" class=\"abstract_t\">27</a>]. Histopathologically, the absence of needle-shaped clefts within lesional fat in cold panniculitis distinguishes it from SCFN; additionally, cystic spaces thought to correlate with ruptured fat calls may be seen in cold panniculitis [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/25,26\" class=\"abstract_t\">25,26</a>]. (See <a href=\"topic.htm?path=panniculitis-recognition-and-diagnosis\" class=\"medical medical_review\">&quot;Panniculitis: Recognition and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Sclerema neonatorum </strong>&ndash; Sclerema neonatorum is a rare panniculitis that affects critically ill preterm and low-birthweight newborns and is associated with a high mortality rate [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/28\" class=\"abstract_t\">28</a>]. Skin tightens symmetrically and becomes fixed to underlying tissues. Hardened skin may appear waxy, purple, or mottled. Generally, the eruption spreads quickly to involve all skin with underlying fat but spares genitalia, palms, and soles, which lack subcutaneous adipose tissue. Joint contractures, impairment of chest wall movement with respiration, and feeding difficulty may occur. Histopathology shows needle-shaped clefts within adipocytes similar to those seen in SCFN, but the lack of inflammatory cells in sclerema neonatorum differentiates it from SCFN [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/25,26\" class=\"abstract_t\">25,26</a>]. (See <a href=\"topic.htm?path=sclerema-neonatorum\" class=\"medical medical_review\">&quot;Sclerema neonatorum&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Scleredema </strong>&ndash;<strong> </strong>Scleredema is a rare condition that develops in newborns exposed to cold environments or severe infection during the first week of life. In scleredema, affected skin is thickened, wax-like, and edematous. In contrast to SCFN and sclerema neonatorum, scleredema demonstrates pitting upon pressure and tends to affect the legs preferentially [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/28\" class=\"abstract_t\">28</a>]. Histopathology demonstrates edema of the dermis and subcutaneous fat and a lymphohistiocytic lobular panniculitis. Infantile scleredema must be distinguished from adult scleredema; thickening of collagen and increased mucin are noted only in adult scleredema (scleredema adultorum of Buschke). (See <a href=\"topic.htm?path=scleredema\" class=\"medical medical_review\">&quot;Scleredema&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1014041218\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The nodules and plaques of subcutaneous fat necrosis of the newborn (SCFN) typically resolve spontaneously without scarring over several weeks [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/29\" class=\"abstract_t\">29</a>]. Infrequently, skin lesions ulcerate or evolve into liquid-filled bullae that require local skin care. Pain with SCFN occurs in approximately 25 percent of cases and requires appropriate analgesic treatment [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/12\" class=\"abstract_t\">12</a>]. In cases where opioids do not alleviate pain adequately, addition of systemic corticosteroids may be helpful [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=prevention-and-treatment-of-neonatal-pain\" class=\"medical medical_review\">&quot;Prevention and treatment of neonatal pain&quot;</a>.)</p><p>Because the onset of hypercalcemia may be delayed, serum calcium levels must be monitored for several months after the diagnosis. SCFN-associated hypercalcemia is treated with restriction of supplemental calcium and vitamin D, hyperhydration with intravenous fluids, and calcium-wasting loop diuretics (eg, <a href=\"topic.htm?path=furosemide-pediatric-drug-information\" class=\"drug drug_pediatric\">furosemide</a>) [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/15\" class=\"abstract_t\">15</a>]. In more severe cases, systemic corticosteroids and bisphosphonates have been used to help manage SCFN-associated hypercalcemia. Bisphosphonates appear to regulate calcium levels more quickly than systemic corticosteroids [<a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/31\" class=\"abstract_t\">31</a>].</p><p class=\"headingAnchor\" id=\"H1806886391\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Subcutaneous fat necrosis of the newborn (SCFN) is a self-limited panniculitis that most often affects full-term newborns who undergo birth asphyxia, other perinatal stress, or therapeutic hypothermia. Additional risk factors include maternal diabetes, hypothyroidism, hypertension, and preeclampsia, as well as placental abruption. (See <a href=\"#H1052661153\" class=\"local\">'Introduction'</a> above and <a href=\"#H1358228590\" class=\"local\">'Risk factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>SCFN develops in the first weeks of life with indurated, red-to-purple nodules and plaques on the posterior trunk (<a href=\"image.htm?imageKey=DERM%2F112136%7EDERM%2F83790\" class=\"graphic graphic_picture graphicRef112136 graphicRef83790 \">picture 1A-B</a>), buttocks, and cheeks. Hypercalcemia is a potentially life-threatening complication of SCFN that requires close monitoring and appropriate treatment. (See <a href=\"#H2228797353\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of SCFN is usually clinical. However, if the clinical diagnosis is in question, a skin biopsy can provide histopathologic&nbsp;confirmation. (See <a href=\"#H1738286987\" class=\"local\">'Diagnosis'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>SCFN nodules and plaques generally involute without scarring within several weeks. SCFN-associated hypercalcemia is managed by restricting calcium and vitamin D intake, intravenous fluid hyperhydration, and utilization of calcium-wasting loop diuretics. Blood calcium levels must be monitored for several months in affected infants. (See <a href=\"#H1014041218\" class=\"local\">'Management'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/1\" class=\"nounderline abstract_t\">Hicks MJ, Levy ML, Alexander J, Flaitz CM. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr Dermatol 1993; 10:271.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/2\" class=\"nounderline abstract_t\">Del Pozzo-Maga&ntilde;a BR, Ho N. Subcutaneous Fat Necrosis of the Newborn: A 20-Year Retrospective Study. Pediatr Dermatol 2016; 33:e353.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/3\" class=\"nounderline abstract_t\">Hogeling M, Meddles K, Berk DR, et al. Extensive subcutaneous fat necrosis of the newborn associated with therapeutic hypothermia. Pediatr Dermatol 2012; 29:59.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/4\" class=\"nounderline abstract_t\">Mitra S, Dove J, Somisetty SK. Subcutaneous fat necrosis in newborn-an unusual case and review of literature. Eur J Pediatr 2011; 170:1107.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/5\" class=\"nounderline abstract_t\">Farooque A, Moss C, Zehnder D, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol 2009; 160:423.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/6\" class=\"nounderline abstract_t\">Kruse K, Irle U, Uhlig R. Elevated 1,25-dihydroxyvitamin D serum concentrations in infants with subcutaneous fat necrosis. J Pediatr 1993; 122:460.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/7\" class=\"nounderline abstract_t\">Cook JS, Stone MS, Hansen JR. Hypercalcemia in association with subcutaneous fat necrosis of the newborn: studies of calcium-regulating hormones. Pediatrics 1992; 90:93.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/8\" class=\"nounderline abstract_t\">Sharata H, Postellon DC, Hashimoto K. Subcutaneous fat necrosis, hypercalcemia, and prostaglandin E. Pediatr Dermatol 1995; 12:43.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/9\" class=\"nounderline abstract_t\">Metz SA, Hassal E. PGE, hypercalcemia, and subcutaneous fat necrosis. J Pediatr 1980; 97:336.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/10\" class=\"nounderline abstract_t\">Beuzeboc G&eacute;rard M, Aillet S, Bertheuil N, et al. Surgical management of subcutaneous fat necrosis of the newborn required due to a lack of improvement: a very rare case. Br J Dermatol 2014; 171:183.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/11\" class=\"nounderline abstract_t\">Thomas JM, Bhandari J, Rytina E, et al. Subcutaneous Fat Necrosis of the Neonate with a Delayed Second Eruption. Pediatr Dermatol 2016; 33:e134.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/12\" class=\"nounderline abstract_t\">Mah&eacute; E, Girszyn N, Hadj-Rabia S, et al. Subcutaneous fat necrosis of the newborn: a systematic evaluation of risk factors, clinical manifestations, complications and outcome of 16 children. Br J Dermatol 2007; 156:709.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/13\" class=\"nounderline abstract_t\">Mah&eacute; E, De Prost Y. [Subcutaneous fat necrosis of the newborn]. Ann Dermatol Venereol 2007; 134:494.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/14\" class=\"nounderline abstract_t\">Burden AD, Krafchik BR. Subcutaneous fat necrosis of the newborn: a review of 11 cases. Pediatr Dermatol 1999; 16:384.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/15\" class=\"nounderline abstract_t\">Shumer DE, Thaker V, Taylor GA, Wassner AJ. Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications. Arch Dis Child Fetal Neonatal Ed 2014; 99:F419.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/16\" class=\"nounderline abstract_t\">Borgia F, De Pasquale L, Cacace C, et al. Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemia. J Paediatr Child Health 2006; 42:316.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/17\" class=\"nounderline abstract_t\">Canpolat N, &Ouml;zdil M, Kuru&#287;o&#287;lu S, et al. Nephrocalcinosis as a complication of subcutaneous fat necrosis of the newborn. Turk J Pediatr 2012; 54:667.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/18\" class=\"nounderline abstract_t\">Nair S, Nair SG, Borade A, Ramakrishnan K. Hypercalcemia and metastatic calcification in a neonate with subcutaneous fat necrosis. Indian J Pediatr 2009; 76:1155.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/19\" class=\"nounderline abstract_t\">Tran JT, Sheth AP. Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature. Pediatr Dermatol 2003; 20:257.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/20\" class=\"nounderline abstract_t\">Schubert PT, Razak R, Jordaan HF. Fine-Needle Aspiration as a Method of Diagnosis of Subcutaneous Fat Necrosis of the Newborn. Pediatr Dermatol 2016; 33:e220.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/21\" class=\"nounderline abstract_t\">Schubert PT, Razack R, Vermaak A, Jordaan HF. Fine-needle aspiration cytology of subcutaneous fat necrosis of the newborn: the cytology spectrum with review of the literature. Diagn Cytopathol 2012; 40:245.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/22\" class=\"nounderline abstract_t\">Vasireddy S, Long SD, Sacheti B, Mayforth RD. MRI and US findings of subcutaneous fat necrosis of the newborn. Pediatr Radiol 2009; 39:73.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/23\" class=\"nounderline abstract_t\">Srinath G, Cohen M. Imaging findings in subcutaneous fat necrosis in a newborn. Pediatr Radiol 2006; 36:361.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/24\" class=\"nounderline abstract_t\">Anderson DR, Narla LD, Dunn NL. Subcutaneous fat necrosis of the newborn. Pediatr Radiol 1999; 29:794.</a></li><li class=\"breakAll\">Weedon D. Panniculitis. In: Weedon's Skin Pathology, 3rd ed, Weedon D (Ed), Churchill Livingstone/Elsevier, Edinburgh 2010. p.1041.</li><li class=\"breakAll\">Rapini RP. Practical Dermatopathology, Elsevier Mosby, Philadelphia 2005.</li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/27\" class=\"nounderline abstract_t\">Markus JR, de Carvalho VO, Abagge KT, Percicotte L. Ice age: a case of cold panniculitis. Arch Dis Child Fetal Neonatal Ed 2011; 96:F200.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/28\" class=\"nounderline abstract_t\">Zeb A, Darmstadt GL. Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management. J Perinatol 2008; 28:453.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/29\" class=\"nounderline abstract_t\">Ak&#305;n MA, Ak&#305;n L, Sar&#305;c&#305; D, et al. Follow-up during early infancy of newborns diagnosed with subcutaneous fat necrosis. J Clin Res Pediatr Endocrinol 2011; 3:216.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/30\" class=\"nounderline abstract_t\">Wiadrowski TP, Marshman G. Subcutaneous fat necrosis of the newborn following hypothermia and complicated by pain and hypercalcaemia. Australas J Dermatol 2001; 42:207.</a></li><li><a href=\"https://www.uptodate.com/contents/subcutaneous-fat-necrosis-of-the-newborn/abstract/31\" class=\"nounderline abstract_t\">Akin MA, Akin L, Coban D, et al. Post-operative subcutaneous fat necrosis in a newborn: a case report. Fetal Pediatr Pathol 2011; 30:363.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13738 Version 3.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1806886391\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1052661153\" id=\"outline-link-H1052661153\">INTRODUCTION</a></li><li><a href=\"#H1524817707\" id=\"outline-link-H1524817707\">EPIDEMIOLOGY</a><ul><li><a href=\"#H1358228590\" id=\"outline-link-H1358228590\">Risk factors</a></li></ul></li><li><a href=\"#H3583928656\" id=\"outline-link-H3583928656\">PATHOGENESIS</a></li><li><a href=\"#H2228797353\" id=\"outline-link-H2228797353\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H195823984\" id=\"outline-link-H195823984\">Clinical course</a></li></ul></li><li><a href=\"#H1738286987\" id=\"outline-link-H1738286987\">DIAGNOSIS</a><ul><li><a href=\"#H1638911239\" id=\"outline-link-H1638911239\">Pathology</a></li></ul></li><li><a href=\"#H4233786213\" id=\"outline-link-H4233786213\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1014041218\" id=\"outline-link-H1014041218\">MANAGEMENT</a></li><li><a href=\"#H1806886391\" id=\"outline-link-H1806886391\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/13738|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/112136\" class=\"graphic graphic_picture\">- Subcutaneous fat necrosis newborn 2</a></li><li><a href=\"image.htm?imageKey=DERM/83790\" class=\"graphic graphic_picture\">- Subcutaneous fat necrosis of the newborn</a></li><li><a href=\"image.htm?imageKey=DERM/83785\" class=\"graphic graphic_picture\">- Cold panniculitis on cheek</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=panniculitis-recognition-and-diagnosis\" class=\"medical medical_review\">Panniculitis: Recognition and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-and-treatment-of-neonatal-pain\" class=\"medical medical_review\">Prevention and treatment of neonatal pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scleredema\" class=\"medical medical_review\">Scleredema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sclerema-neonatorum\" class=\"medical medical_review\">Sclerema neonatorum</a></li></ul></div></div>","javascript":null}